EVERSANA Named AI Company of the Year by BioTech Breakthrough

CHICAGO – November 6, 2025 – EVERSANA®, a leading provider of commercialization services to the global life sciences industry, has been named the 2025 AI Company of the Year by BioTech Breakthrough. The annual recognition program celebrates organizations driving change through technology and scientific advancements.

“This award reflects our mission to push all boundaries in life science commercialization,” said Mark Thierer, CEO, EVERSANA. “It validates the transformative power of our commitment to ‘Pharmatizing AI’ for maximum client and patient impact. With the added power of AI, we are creating a healthier world.”

Affirming the company’s leadership in AI-powered platforms, partnerships and top talent, EVERSANA was recognized for its cutting-edge AI solutions. Key launches and announcements in 2025 included:

• Google partnership to launch EVERSANA’s AI Agency platform, the industry’s first end-to-end, AI-powered agency that revolutionizes traditional pharma marketing with unmatched precision, speed, and impact.
• EVERSANA ORCHESTRATE™ MLR, which automates up to 90% of the Medical, Legal, and Regulatory review process, providing clients with unmatched accuracy, efficiency, and compliance.
• EVERSANA ORCHESTRATE™ PV, an AI-powered pharmacovigilance platform for faster drug safety operations to meet growing compliance requirements.
• EVERSANA AI Accelerator, a center of excellence to drive industry transformation with the power of AI to provide clients with leading expertise, technologies, and partners.
• Merger of Waltz Health to EVERSANA, forming a unified healthcare platform that redefines pharmaceutical commercialization and patient access.

These milestones, along with four consecutive AI Excellence Awards, reinforce EVERSANA’s leadership in AI innovation. For a full list of winners, visit https://biotechbreakthroughawards.com/.

###

About EVERSANA®

EVERSANA® is a leading independent provider of global services to the life sciences industry. The company’s integrated solutions are rooted in the patient experience and span all stages of the product life cycle to deliver long-term, sustainable value for patients, prescribers, channel partners, and payers. The company serves more than 650 organizations, including innovative start-ups and established pharmaceutical companies, to advance life sciences solutions for a healthier world. To learn more about EVERSANA, visit eversana.com or connect through LinkedIn and X.

Media Contact:
Matt Braun
Vice President, Corporate Communications
matt.braun@eversana.com